OSE Immunotherapeutics SA (ORPOF) Discusses Strategic Plan With Four Opportunities for Value Creation Transcript

Core Viewpoint - OSE Immunotherapeutics has announced a strategic plan, with a focus on leadership changes and future directions for the company [1] Group 1: Leadership Changes - Marc Le Bozec has been appointed as the CEO of OSE Immunotherapeutics, having been elected to the Board of Directors on September 30 and appointed CEO shortly thereafter [1] - The company is in a transitional phase with new leadership aiming to implement the strategic plan [1] Group 2: Strategic Plan Discussion - The webcast will cover the strategic plan announced by the company, indicating a structured approach to future initiatives [1] - The discussion will include insights from key executives, including the CEO and CFO, highlighting their roles in the execution of the strategic plan [1]